BLISSGVS.NS WACC - Weighted Average Cost of Capital

The WACC of Bliss GVS Pharma Ltd (BLISSGVS.NS) is 14.9%.

The Cost of Equity of Bliss GVS Pharma Ltd (BLISSGVS.NS) is 15.10%.

The Cost of Debt of Bliss GVS Pharma Ltd (BLISSGVS.NS) is 7.80%.

	Range	Selected
Cost of equity	13.80% - 16.40%	15.10%
Tax rate	28.60% - 29.40%	29.00%
Cost of debt	7.50% - 8.10%	7.80%
WACC	13.6% - 16.1%	14.9%

WACC

BLISSGVS.NS WACC calculation

Category	Low	High

Long-term bond rate	6.9%	7.4%
Equity market risk premium	8.3%	9.3%
Adjusted beta	0.84	0.92

Additional risk adjustments	0.0%	0.5%
Cost of equity	13.80%	16.40%

Tax rate	28.60%	29.40%
Debt/Equity ratio	0.03	0.03
Cost of debt	7.50%	8.10%

After-tax WACC	13.6%	16.1%


Selected WACC	14.9%

BLISSGVS.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for BLISSGVS.NS:

cost_of_equity (15.10%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.84) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.